Boston Scientific Action

Boston Scientific EBITDA

EBITDA (Résultat avant intérêts, impôts, amortissements et dépréciations) de Boston Scientific (BSX) au 31 juil. 2026 est 4,87 Md USD. L'année précédente, EBITDA (Résultat avant intérêts, impôts, amortissements et dépréciations) était 3,49 Md USD — une variation de 39,44 % (plus élevé).

EBITDA

4,87 MdUSD

YoY

39,44%

Dernière mise à jour:

EBITDA (Résultat avant intérêts, impôts, amortissements et dépréciations) de Boston Scientific est 2026 4,87 Md USD. EBITDA (Résultat avant intérêts, impôts, amortissements et dépréciations) de Boston Scientific était 2025 3,49 Md USD. Elle diminue ainsi de 39,44% plus élevé par rapport à l'année précédente.
Access this data via the Eulerpool API

Boston Scientific Analyse d'actions

Que fait Boston Scientific ? Boston Scientific Corp. is an innovative medical technology company specializing in the development and manufacturing of solutions for medical challenges and needs. Founded in 1979, the company is dedicated to meeting the individual needs of patients and healthcare professionals with innovative products. History: Boston Scientific's history began in the 1960s when French engineer Jean-Marc Simon started developing pacemakers at the University of Minnesota. In 1969, Medtronic acquired Simon's pacemaker development, after which Simon founded Boston Scientific. From the beginning, the company focused on manufacturing cardiovascular implants, including pacemakers, implantable defibrillators, and stents. In the following years, the company pursued continuous growth through acquisitions of competitors and advancements in research and development, particularly in the field of minimally invasive procedures. Today, Boston Scientific is a global leader in innovative medical devices and solutions used in various areas of healthcare. Business Model: Boston Scientific's business model is centered around meeting the needs of patients, healthcare professionals, and healthcare policymakers to improve healthcare. The company works closely with doctors, hospitals, nursing facilities, and research institutions to continuously develop innovative solutions for various diseases and conditions. Boston Scientific has five business segments: Cardiovascular Systems, Interventional Oncology and Neuromodulation, Urology and Women's Health, Medical Oncology, and Endoscopy. Conclusion: Overall, Boston Scientific Corp. is a global leader in innovative medical devices and solutions that span across different business segments. With a significant focus on research and development, the company offers a wide range of products to provide patients worldwide with access to innovative medical care. Through forward-thinking innovations, the development of new technologies, and collaboration with healthcare professionals, Boston Scientific will continue to defend its position as a leading provider of medical solutions worldwide. Boston Scientific est l'une des entreprises les plus populaires sur Eulerpool.

Questions fréquemment posées sur l'action Boston Scientific

EBITDA (Résultat avant intérêts, impôts, amortissements et dépréciations) de Boston Scientific s'élève à 4,87 Md USD en 2026.

Access this data via the Eulerpool API

Compte de résultat — Boston Scientific

Toutes les Métriques Clés — Boston Scientific

Croissance